印度国家肝病研究学会急性肝衰竭共识声明(第二部分):急性肝衰竭的管理
该共识指出急性肝衰竭在印度常见病因为病毒性肝炎,其次为抗结核药物性肝损伤;临床表现为黄疸、脑病和凝血功能障碍。肝性脑病与脑水肿是病程核心事件,其后叠加感染,决定患者结局。氨在脑病和脑水肿发病中起关键作用,多种治疗针对降氨,新型降氨药作用仍在演变。患者最好在具备肝移植条件的三级医院管理,积极重症内科治疗可挽救相当比例患者;对预后不良者,肝移植是唯一被证明能改善生存的有效治疗,但识别预后不良的合适患者仍是挑战。密切监测、早期识别和处理并发症、移植咨询构成一线管理策略;近期研究显示动态预后模型更利于筛选肝移植患者,及时移植可挽救预后不良的急性肝衰竭患者生命。
要点
- 肝性脑病和脑水肿是急性肝衰竭病程中最核心的临床事件,其后叠加感染,决定患者结局。
- 氨在肝性脑病和脑水肿发病中起关键作用,多种治疗针对降氨,新型降氨药作用仍在演变。
- 患者最好在具备肝移植条件的三级医院管理,积极重症内科治疗可挽救相当比例患者。
- 对预后不良者,肝移植是唯一被证明能改善生存的有效治疗,但识别合适患者仍是挑战。
- 近期研究显示动态预后模型更利于筛选肝移植患者,及时移植可挽救预后不良的急性肝衰竭患者生命。
适用人群与场景
- 急性肝衰竭患者,临床表现为黄疸、脑病和凝血功能障碍;印度常见病因为病毒性肝炎,其次为抗结核药物性肝损伤。
处置流程与药物剂量
- 患者最好在具备肝移植条件的三级医院管理。
- 采取积极重症内科治疗;密切监测、早期识别和处理并发症、移植咨询构成一线管理策略。
- 对预后不良者行肝移植;近期研究显示使用动态预后模型更利于筛选肝移植患者。
红旗征与不能漏的情况
- 肝性脑病和脑水肿是急性肝衰竭病程中最核心的临床事件,决定患者结局。
- 感染叠加于肝性脑病和脑水肿之后,影响结局。
证据类型、等级与局限
- 证据类型:印度国家肝病研究学会共识声明(指南/共识)。
- 局限:原文未报告局限性
对床旁实践的改变
- 作者认为急性肝衰竭患者最好在具备肝移植条件的三级医院管理,积极重症内科治疗可挽救相当比例患者。
- 作者认为对预后不良者肝移植是唯一被证明能改善生存的有效治疗;近期研究显示动态预后模型更利于筛选肝移植患者,及时移植可挽救预后不良的急性肝衰竭患者生命。
指南或共识出处
- 印度国家肝病研究学会急性肝衰竭共识声明(第二部分):急性肝衰竭的管理,发表于J Clin Exp Hepatol。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「研究设计与关键结果」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Acute liver failure (ALF) is not an uncommon complication of a common disease such as acute hepatitis. Viral hepatitis followed by antituberculosis drug-induced hepatotoxicity are the commonest causes of ALF in India. Clinically, such patients present with appearance of jaundice, encephalopathy, and coagulopathy. Hepatic encephalopathy (HE) and cerebral edema are central and most important clinical event in the course of ALF, followed by superadded infections, and determine the outcome in these patients. The pathogenesis of encephalopathy and cerebral edema in ALF is unique and multifactorial. Ammonia plays a crucial role in the pathogenesis, and several therapies aim to correct this abnormality. The role of newer ammonia-lowering agents is still evolving. These patients are best managed at a tertiary care hospital with facility for liver transplantation (LT). Aggressive intensive medical management has been documented to salvage a substantial proportion of patients. In those with poor prognostic factors, LT is the only effective therapy that has been shown to improve survival. However, recognizing suitable patients with poor prognosis has remained a challenge. Close monitoring, early identification and treatment of complications, and couseling for transplant form the first-line approach to manage such patients. Recent research shows that use of dynamic prognostic models is better for selecting patients undergoing liver transplantation and timely transplant can save life of patients with ALF with poor prognostic factors.
参考来源
- Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure. J Clin Exp Hepatol. 2020. PMID: 33029057. doi:10.1016/j.jceh.2020.04.011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。